• RI - Unifesp
    • Documentos
    • Tutoriais
    • Perguntas frequentes
    • Atendimento
    • Equipe
    • português (Brasil)
    • English
    • español
  • Sobre
    • RI Unifesp
    • Documentos
    • Tutoriais
    • Perguntas frequentes
    • Atendimento
    • Equipe
  • English 
    • português (Brasil)
    • English
    • español
    • português (Brasil)
    • English
    • español
  • Login
View Item 
  •   DSpace Home
  • Escola Paulista de Medicina (EPM)
  • EPM - Artigos
  • View Item
  •   DSpace Home
  • Escola Paulista de Medicina (EPM)
  • EPM - Artigos
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Brazilian guidelines for the clinical management of paracoccidioidomycosis

Thumbnail
View/Open
WOS000414732300025.pdf (5.738Mb)
Date
2017
Author
Shikanai-Yasuda, Maria Aparecida
Mendes, Rinaldo Poncio
Colombo, Arnaldo Lopes [UNIFESP]
de Queiroz-Telles, Flavio
Goncalves Kono, Adriana Satie
Paniago, Anamaria M. M.
Nathan, Andre
Francisconi do Valle, Antonio Carlos
Bagagli, Eduardo
Benard, Gil
Ferreira, Marcelo Simao
Teixeira, Marcus de Melo
Silva-Vergara, Mario Leon
Pereira, Ricardo Mendes
Cavalcante, Ricardo de Souza
Hahn, Rosane
Durlacher, Rui Rafael
Khoury, Zarifa
de Camargo, Zoilo Pires [UNIFESP]
Moretti, Maria Luiza
Martinez, Roberto
Type
Artigo
ISSN
0037-8682
DOI
10.1590/0037-8682-0230-2017
Metadata
Show full item record
Abstract
Paracoccidioidomycosis is a systemic fungal disease occurring in Latin America that is associated with rural environments and agricultural activities. However, the incidence and prevalence of paracoccidiodomycosis is underestimated because of the lack of compulsory notification. If paracoccidiodomycosis is not diagnosed and treated early and adequately, the endemic fungal infection could result in serious sequelae. While the Paracoccidioides brasiliensis (P. brasiliensis) complex has been known to be the causal agent of paracoccidiodomycosis, a new species, Paracoccidioides lutzii (P. lutzii), has been reported in Rondonia, where the disease has reached epidemic levels, and in the Central West and Para. Accurate diagnoses and availability of antigens that are reactive with the patients' sera remain significant challenges. Therefore, the present guidelines aims to update the first Brazilian consensus on paracoccidioidomycosis by providing evidence-based recommendations for bedside patient management. This consensus summarizes etiological, ecoepidemiological, molecular epidemiological, and immunopathological data, with emphasis on clinical, microbiological, and serological diagnosis and management of clinical forms and sequelae, as well as in patients with comorbidities and immunosuppression. The consensus also includes discussion of outpatient treatments, severe disease forms, disease prevalence among special populations and resource-poor settings, a brief review of prevention and control measures, current challenges and recommendations.
Citation
Revista Da Sociedade Brasileira De Medicina Tropical. Brasilia, v. 50, n. 5, p. 715-740, 2017.
Keywords
Paracoccidioidomycosis
Guidelines
Clinical management
Diagnosis
Treatment follow-up
Sponsorship
Brazilian Society of Tropical Medicine and Hygiene
Brazilian Society of Infectology and Sociedade Paulista de Infectologia
Departamento de Moléstias Infecciosas e Parasitárias da FMUSP
URI
http://repositorio.unifesp.br/handle/11600/51253
Collections
  • EPM - Artigos [16302]

DSpace software copyright © 2002-2016  DuraSpace
Contact Us
Theme by 
Atmire NV
 

 

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsBy Submit DateThis CollectionBy Issue DateAuthorsTitlesSubjectsBy Submit Date

My Account

Login

Statistics

View Usage Statistics

DSpace software copyright © 2002-2016  DuraSpace
Contact Us
Theme by 
Atmire NV